The correct name for Dagliflozin is Dagliflozin Tablets. Serious side effects of Dagliflozin Tablets include conditions such as low blood pressure, ketoacidosis, acute renal impairment, urinary sepsis, pyelonephritis, hypoglycemia due to the combined use of insulin or insulinotropic agents, diseases of fungal infections of the genitals, elevated levels of low-density lipoprotein (LDL) cholesterol, bladder cancer, and other conditions. Dagliflozin tablets are used as a single-agent treatment for adult patients with type 2 diabetes mellitus based on controlled diet and exercise. However, Dagliflozin Tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis. In addition, Dagliflozin Tablets are contraindicated in patients with severe hypersensitivity to Dagliflozin Tablets and its components; in patients with severe renal impairment, end-stage renal disease, and patients requiring dialysis treatment; pregnant women and lactating women are advised to use the drug with caution on balance; and the efficacy of the drug in pediatric patients under 18 years of age has not been established. If you need to take Dagliflozin tablets, it is recommended to consult a professional doctor and follow the doctor’s instructions to standardize the treatment, not blindly self-medication.